US Stock MarketDetailed Quotes

Lexicon Pharmaceuticals (LXRX)

Watchlist
  • 1.760
  • +0.200+12.82%
Close Jan 22 16:00 ET
  • 1.780
  • +0.020+1.12%
Pre 08:06 ET
639.58MMarket Cap-9.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexicon Pharmaceuticals (LXRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
Operating revenue
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
Cost of revenue
-85.92%10K
-80.12%33K
-3.23%30K
624.71%616K
397.14%348K
914.29%71K
1,975.00%166K
31K
85K
70K
Gross profit
744.07%14.17M
1,846.86%28.83M
12.10%1.23M
2,622.52%30.47M
4,046.52%26.21M
983.23%1.68M
379.29%1.48M
4,479.17%1.1M
705.04%1.12M
2,157.14%632K
Operating expense
-59.68%26.36M
-55.84%25.1M
-42.04%26.91M
31.65%227.58M
24.43%58.94M
31.31%65.37M
27.58%56.84M
48.98%46.43M
71.33%172.87M
56.30%47.37M
Selling and administrative expenses
-80.80%7.6M
-76.14%9.35M
-63.79%11.61M
25.55%143.1M
-1.07%32.26M
22.85%39.59M
30.61%39.19M
67.50%32.06M
137.05%113.98M
99.69%32.61M
-General and administrative expense
----
----
----
----
----
----
----
67.50%32.06M
----
----
Research and development costs
-27.24%18.76M
-10.75%15.75M
6.48%15.3M
43.46%84.48M
80.77%26.69M
46.83%25.78M
21.33%17.64M
19.51%14.37M
11.49%58.89M
5.62%14.76M
Operating profit
80.87%-12.19M
106.75%3.74M
43.35%-25.68M
-14.77%-197.12M
29.95%-32.74M
-28.33%-63.69M
-25.12%-55.35M
-45.57%-45.33M
-70.45%-171.75M
-54.36%-46.74M
Net non-operating interest income expense
47.94%-582K
-125.14%-484K
112.53%384K
38.80%-3.29M
65.92%-1.03M
-25.06%-1.12M
389.91%1.93M
-286.87%-3.06M
-353.46%-5.37M
-1,297.69%-3.02M
Non-operating interest income
-54.33%1.57M
-55.66%1.83M
17.78%2.22M
58.99%12.29M
17.78%2.83M
14.61%3.44M
219.14%4.14M
83.09%1.88M
384.46%7.73M
170.80%2.4M
Non-operating interest expense
-52.76%2.16M
4.84%2.32M
-62.91%1.84M
18.91%15.58M
-28.83%3.86M
17.00%4.56M
12.81%2.21M
171.72%4.95M
371.26%13.1M
391.48%5.42M
Other net income (expense)
Income before tax
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
Income tax
Net income
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
Net income continuous Operations
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
Minority interest income
Net income attributable to the parent company
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
Basic earnings per share
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
Diluted earnings per share
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K
Operating revenue 710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K
Cost of revenue -85.92%10K-80.12%33K-3.23%30K624.71%616K397.14%348K914.29%71K1,975.00%166K31K85K70K
Gross profit 744.07%14.17M1,846.86%28.83M12.10%1.23M2,622.52%30.47M4,046.52%26.21M983.23%1.68M379.29%1.48M4,479.17%1.1M705.04%1.12M2,157.14%632K
Operating expense -59.68%26.36M-55.84%25.1M-42.04%26.91M31.65%227.58M24.43%58.94M31.31%65.37M27.58%56.84M48.98%46.43M71.33%172.87M56.30%47.37M
Selling and administrative expenses -80.80%7.6M-76.14%9.35M-63.79%11.61M25.55%143.1M-1.07%32.26M22.85%39.59M30.61%39.19M67.50%32.06M137.05%113.98M99.69%32.61M
-General and administrative expense ----------------------------67.50%32.06M--------
Research and development costs -27.24%18.76M-10.75%15.75M6.48%15.3M43.46%84.48M80.77%26.69M46.83%25.78M21.33%17.64M19.51%14.37M11.49%58.89M5.62%14.76M
Operating profit 80.87%-12.19M106.75%3.74M43.35%-25.68M-14.77%-197.12M29.95%-32.74M-28.33%-63.69M-25.12%-55.35M-45.57%-45.33M-70.45%-171.75M-54.36%-46.74M
Net non-operating interest income expense 47.94%-582K-125.14%-484K112.53%384K38.80%-3.29M65.92%-1.03M-25.06%-1.12M389.91%1.93M-286.87%-3.06M-353.46%-5.37M-1,297.69%-3.02M
Non-operating interest income -54.33%1.57M-55.66%1.83M17.78%2.22M58.99%12.29M17.78%2.83M14.61%3.44M219.14%4.14M83.09%1.88M384.46%7.73M170.80%2.4M
Non-operating interest expense -52.76%2.16M4.84%2.32M-62.91%1.84M18.91%15.58M-28.83%3.86M17.00%4.56M12.81%2.21M171.72%4.95M371.26%13.1M391.48%5.42M
Other net income (expense)
Income before tax 80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M
Income tax
Net income 80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M
Net income continuous Operations 80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M
Minority interest income
Net income attributable to the parent company 80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M
Basic earnings per share 77.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2
Diluted earnings per share 77.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -